PURPOSE 1 tracked over 5,000 cisgender women in South Africa and Uganda starting in 2021. Not a single woman who received lenacapavir contracted HIV …
Read more: HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval – NPR
Tags: South Africa